Australia's most trusted
source of pharma news
Friday, 03 May 2024
Posted 19 April 2024 PM
While the average salary increase for full-time pharma employees in the US sits between two and three per cent, it's a very different story for those steering the ship with many CEOs winning bumper pay hikes on the back of major sales success.
The top five pay increases by percentage for pharma CEOs in 2023 ranged from a handsome 21 per cent to a breathtaking 117 per cent with remuneration packages spanning from AU$23 million to AU$42 million.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.